Expert Review of Hematology, Volume 10, Issue 10 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 10, Issue 10 (2017)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Volume 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Special Report

Article
Simultaneous bilateral total knee arthroplasty in hemophilia: is it recommended?
E. Carlos Rodriguez-Merchan
Pages: 847-851
Published online: 31 Jul 2017
AbstractforSimultaneous bilateral total knee arthroplasty in hemophilia: is it recommended? | Full Text | References | PDF (490.1 KB)
  • 215 Views
  • 4 CrossRef citations
  • 0Altmetric

Drug Profile

Article
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?
Claudia Brunetti, Luisa Anelli, Antonella Zagaria, Giorgina Specchia & Francesco Albano
Pages: 853-862
Published online: 24 Aug 2017
AbstractforCPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? | Full Text | References | PDF (1.1 MB)
  • 543 Views
  • 19 CrossRef citations
  • 0Altmetric

Review

Review
Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199
Kiran Naqvi, Marina Konopleva & Farhad Ravandi
Pages: 863-874
Published online: 21 Aug 2017
AbstractforTargeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199 | Full Text | References | PDF (908.3 KB)
  • 903 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention
Natalie R. Shilo & Claudia R. Morris
Pages: 875-890
Published online: 23 Aug 2017
AbstractforPathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention | Full Text | References | PDF (1.7 MB)
  • 398 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Fertility challenges for women with sickle cell disease
Djamila L. Ghafuri, Sarah-Jo Stimpson, Melissa E. Day, Andra James, Michael R. DeBaun & Deva Sharma
Pages: 891-901
Published online: 11 Sep 2017
AbstractforFertility challenges for women with sickle cell disease | Full Text | References | PDF (839.3 KB)
  • 1127 Views
  • 22 CrossRef citations
  • 0Altmetric
Review
Immunotherapy based approaches in myelofibrosis
Lucia Masarova, Srdan Verstovsek, Hagop Kantarjian & Naval Daver
Pages: 903-914
Published online: 22 Aug 2017
AbstractforImmunotherapy based approaches in myelofibrosis | Full Text | References | PDF (1.3 MB)
  • 772 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
ICUS/CCUS/CHIP: basics & beyond
Mili Jain & Anil Tripathi
Pages: 915-920
Published online: 01 Sep 2017
AbstractforICUS/CCUS/CHIP: basics & beyond | Full Text | References | PDF (606 KB)
  • 1046 Views
  • 13 CrossRef citations
  • 0Altmetric
Review
Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors
Gualtiero Palareti
Pages: 921-931
Published online: 21 Aug 2017
AbstractforOptimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors | Full Text | References | PDF (839.8 KB)
  • 146 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent
Paul Richardson, Anuja Roy, Suddhasatta Acharyya, Ashok Panneerselvam, Estella Mendelson, Andreas Günther, Sagar Lonial & Hermann Einsele
Pages: 933-939
Published online: 25 Sep 2017
AbstractforTreatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent | Full Text | References | PDF (721 KB)
  • 269 Views
  • 10 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature
Ra. Sepúlveda Palamara et al.
Review Article | Published online: 6 Jun 2024
Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data
Robert F. Sidonio Jr et al.
Article | Published online: 24 May 2024
Open Access
Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma
Nathalie Javidi-Sharifi et al.
Review Article | Published online: 24 May 2024
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia
Jorge E. Cortes
Review Article | Published online: 21 May 2024
Open Access
View all latest articles